查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2084966

動物抗菌胜肽市場：按產品類型、動物類型、給藥方法、應用和最終用戶分類－2026-2032年全球市場預測

Animal Antibacterial Peptide Market by Product Type, Animal Type, Mode of Delivery, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物抗菌肽市場將成長至 146.8 億美元，複合年成長率為 17.68%。

主要市場統計數據
基準年 2025 46.9億美元
預計年份：2026年 54.2億美元
預測年份 2032 146.8億美元
複合年成長率 (%) 17.68%

動物抗菌肽，包括用於畜牧業、水產養殖、伴侶動物和獸用生技藥品研究的抗菌肽，正變得越來越具有戰略意義，因為動物健康系統正在應對抗生素抗藥性、對合理使用抗生素的更嚴格規定以及對低殘留蛋白質生產日益成長的需求。

這些胜肽是短鏈生物活性分子，能夠破壞微生物細胞膜、調節免疫反應並幫助控制特定病原體。在傳統抗生素面臨監管壓力、抗藥性問題或療效受限的領域，它們的潛在價值最為顯著。世界衛生組織（WHO）、世界動物衛生組織（OIE）和各國獸醫主管部門的全球監測活動也支持了市場對這些胜肽藥物的興趣。這些機構始終將抗菌素抗藥性視為影響人類、動物、食品系統和環境的「同一健康」風險。

市場狀況的變革性變化

動物抗菌肽的市場格局正受到抗生素減量政策、精準畜牧管理以及從單純治療性干預轉向預防性動物保健等因素的重塑。歐盟於2006年禁止使用抗生素生長促進劑，美國則透過《獸用飼料指令》（VFD）加強了對具有重要醫療價值的抗菌劑的獸醫監管。這些政策變化持續影響全球對替代療法的預期。

人工智慧的累積影響

人工智慧透過實現高通量序列篩檢、活性預測、毒性建模以及結構和功能分析，正在加速動物用抗菌肽的發現和最佳化。機器學習模型可以評估胜肽的電荷、疏水性、兩性、分子量和預測的膜相互作用，從而在進行成本高昂的實驗室檢驗之前，對候選物質進行優先排序。

對關鍵區域的洞察

亞太地區是重要的需求中心，這主要得益於大規模的畜牧業存量、集約化水產養殖以及人們對食品安全日益成長的期望。中國、印度、日本、韓國、澳洲和東南亞國協的市場正在加強動物健康基礎設施建設，同時也尋求既能合理使用抗生素，又能與大規模家禽、生豬、​​乳牛和水產養殖相兼容的解決方案。

主要經濟區概況

東協是重要的成長叢集，因為家禽、生豬和水產養殖對區域糧食安全至關重要，生產者越來越重視出口市場標準、殘留物控制和疾病預防。海灣合作理事會的特點是依賴食品進口、集約化家禽和乳牛項目，以及政府主導的糧食安全策略，這些策略強調適用於管理式生產系統的可靠疾病預防工具。

主要國家的概況

美國擁有完善的獸醫監管體系、先進的動物衛生基礎設施，以及對家禽、豬、乳牛、牛和伴侶動物抗生素替代品的強勁需求。加拿大有類似的管理目標和以科學為基礎的獸醫法規，而墨西哥的商業機會則與家禽、豬、乳牛和出口導向食品生產的整合有關。

為行業領導者提供的實用建議

產業領導者應優先考慮具有臨床意義的療效數據、物種特異性療效檢驗以及透明的安全性資訊。應針對高優先級獸醫病原體測試候選胜肽，以評估其抗藥性風險，並與現有抗生素、益生菌、有機酸、酵素和疫苗接種方案進行比較。

調查方法

本執行摘要基於公開認可的來源的二手研究，包括全球一體化健康指南、獸醫抗菌藥物指南、監管出版刊物、同行評審的科學資訊來源、畜牧資料庫和動物健康行業報告。

結論與策略展望

動物抗菌胜肽處於合理使用抗生素、精準動物醫療和永續蛋白質生產的交匯點。隨著生產者和獸醫尋求在不損害動物福利、生產力或食品安全的前提下，有效減少對傳統抗生素依賴的方法，抗菌肽的市場重要性日益凸顯。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：動物抗菌胜肽市場：依產品類型分類

  • 天然來源胜肽
  • 合成胜肽
    • 長鏈
    • 中鏈
    • 短鏈

第8章：動物抗菌胜肽市場：依動物類型分類

  • 肉類動物
    • 牛
    • 家禽
    • 豬
  • 伴侶動物
    • 狗
    • 貓

第9章：動物抗菌胜肽市場：依給藥方法分類

  • 口服
  • 注射藥物
  • 外用

第10章：動物抗菌胜肽市場：依應用領域分類

  • 促進生長
  • 為了預防
    • 疾病預防
    • 疫苗佐劑
  • 治療用途
    • 感染疾病治療
    • 皮膚病的治療

第11章：動物抗菌胜肽市場：依最終用戶分類

  • 水產養殖場
  • 飼料生產商
    • 水產飼料
    • 牲畜飼料
  • 研究機構
    • 學術機構
    • 生技公司
  • 動物診所
    • 大型動物診所
    • 小動物診所

第12章：動物抗菌胜肽市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：動物抗菌胜肽市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：動物抗菌胜肽市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • AB Vista Limited
  • AgroBioTek Laboratories LLC
  • Anitox Corporation
  • Biogenesis Bago SA
  • Biosynth Ltd
  • Boehringer Ingelheim International GmbH
  • Cargill, Incorporated
  • Dechra Pharmaceuticals PLC
  • Eco Animal Health Ltd.
  • Elanco Animal Health Incorporated
  • Esco Aster Pte. Ltd.
  • Genera Inc.
  • Huvepharma SA
  • ImmuCell Corporation
  • Kemin Industries, Inc.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Novozymes A/S
  • Phibro Animal Health Corporation
  • Vetbiochem India Pvt Ltd.
  • Vetoquinol SA
  • Zoetis Inc.
  • Zomedica Pharmaceuticals Corp.
Product Code: MRR-4369010662C8

The Animal Antibacterial Peptide Market is projected to grow by USD 14.68 billion at a CAGR of 17.68% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.69 billion
Estimated Year [2026] USD 5.42 billion
Forecast Year [2032] USD 14.68 billion
CAGR (%) 17.68%

Animal antibacterial peptides, including antimicrobial peptides used in livestock, aquaculture, companion animals, and veterinary biologics research, are gaining strategic relevance as animal health systems respond to antimicrobial resistance, stricter antibiotic stewardship, and rising demand for residue-conscious protein production.

These peptides are short, biologically active molecules that can disrupt microbial membranes, modulate immune responses, and support targeted pathogen control. Their potential value is strongest where conventional antibiotics face regulatory pressure, resistance concerns, or performance limitations. Market interest is supported by global surveillance from the World Health Organization, the World Organisation for Animal Health, and national veterinary agencies, which consistently identify antimicrobial resistance as a One Health risk affecting humans, animals, food systems, and the environment.

Transformative Shifts in the Market Landscape

The landscape for animal antibacterial peptides is being reshaped by antibiotic-reduction policies, precision livestock management, and the shift from therapeutic-only intervention toward preventive animal health. The European Union banned antibiotic growth promoters in 2006, and the United States implemented Veterinary Feed Directive controls to strengthen veterinary oversight of medically important antimicrobials. These policy changes continue to influence global expectations for alternatives.

Commercial development is moving from broad-spectrum substitution to use-case-specific deployment in feed additives, topical veterinary applications, aquaculture disease management, mastitis control research, and companion animal dermatology. Buyers increasingly evaluate efficacy, stability, palatability, delivery format, withdrawal-period implications, and compatibility with probiotics, organic acids, enzymes, vaccines, and biosecurity programs.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating the discovery and optimization of animal antibacterial peptides by enabling high-throughput sequence screening, activity prediction, toxicity modeling, and structure-function analysis. Machine learning models can evaluate peptide charge, hydrophobicity, amphipathicity, molecular weight, and predicted membrane interaction to prioritize candidates before costly wet-lab validation.

AI is also improving formulation and deployment decisions. In animal health, peptide performance depends on species, pathogen load, gut environment, feed processing temperature, delivery route, and microbiome effects. Predictive analytics can help connect farm-level data, veterinary diagnostics, and peptide performance outcomes, supporting more precise use while reducing trial-and-error development cycles.

Key Regional Insights

Asia-Pacific is an important demand center because it combines large livestock populations, aquaculture intensity, and increasing food safety expectations. China, India, Japan, South Korea, Australia, and ASEAN markets are strengthening animal health infrastructure while seeking antibiotic stewardship solutions compatible with high-volume poultry, swine, dairy, and aquaculture production.

North America benefits from advanced veterinary diagnostics, strong animal nutrition capabilities, and established regulatory pathways for veterinary oversight. Latin America, led by Brazil and Mexico, has opportunity tied to poultry, beef, dairy, swine, and export-oriented protein production. Europe remains a regulatory benchmark due to its long-standing restrictions on growth-promoting antibiotics and continued emphasis on antimicrobial reduction, veterinary prescription discipline, and documented responsible use.

The Middle East is developing opportunities through poultry integration, dairy modernization, and food security investment, while Africa presents long-term potential as livestock productivity, veterinary access, cold-chain capacity, and disease prevention programs expand. Across Asia-Pacific, North America, Latin America, Europe, the Middle East, and Africa, adoption depends on local regulatory classification, cost-in-use, evidence quality, manufacturing consistency, and compatibility with existing animal health programs.

Key Economic Group Insights

ASEAN is a relevant growth cluster because poultry, swine, and aquaculture production are central to regional food security, and producers are increasingly attentive to export market standards, residue management, and disease prevention. The GCC is shaped by food import dependence, intensive poultry and dairy projects, and government-backed food security strategies that favor reliable disease-prevention tools suited to controlled production systems.

The European Union remains highly influential for animal antibacterial peptide commercialization because its antimicrobial stewardship framework often sets reference expectations for safety, efficacy, environmental responsibility, and responsible use. BRICS markets combine scale and production diversity, with China, India, Brazil, Russia, and South Africa representing different demand profiles across feed, veterinary, dairy, poultry, swine, and aquaculture applications.

G7 economies contribute advanced research capacity, regulatory science, veterinary diagnostics, and premium animal health purchasing power. NATO countries overlap significantly with high-income veterinary markets, where biosecurity, supply chain resilience, reduced antimicrobial dependence, and preparedness against transboundary animal diseases are increasingly treated as strategic priorities.

Key Country Insights

The United States is supported by sophisticated veterinary oversight, advanced animal health infrastructure, and strong demand for antibiotic alternatives in poultry, swine, dairy, beef, and companion animal care. Canada aligns with similar stewardship objectives and science-based veterinary regulation, while Mexico's opportunity is linked to integrated poultry, swine, dairy, and export-oriented food production.

Brazil is a major opportunity due to its global role in poultry, beef, and pork exports, while the United Kingdom, Germany, France, Italy, and Spain remain important European markets because of mature veterinary systems, established livestock industries, and pressure to document responsible antimicrobial use. Russia's demand is influenced by domestic animal protein production, food security priorities, and import substitution dynamics.

China and India represent scale-driven opportunities across livestock and aquaculture, although commercialization depends on regulatory clarity, cost competitiveness, and reliable field evidence. Japan, Australia, and South Korea offer quality-focused markets with advanced veterinary standards, strong biosecurity cultures, and interest in science-backed animal health innovation, particularly where antimicrobial stewardship aligns with food safety and animal welfare objectives.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically relevant efficacy data, species-specific validation, and transparent safety profiles. Peptide candidates should be tested against priority veterinary pathogens, evaluated for resistance-development risk, and benchmarked against existing antibiotics, probiotics, organic acids, enzymes, and vaccination programs.

Companies should invest in formulation technologies that improve stability during feed processing, gastrointestinal transit, topical use, injectable formats, or water delivery. Strategic partnerships with veterinary universities, diagnostic laboratories, feed integrators, and contract research organizations can shorten validation timelines and strengthen technical credibility.

A successful commercialization strategy should include regulatory mapping by country, cost-in-use modeling, scalable manufacturing, quality control, and clear claims management. Firms should also build post-market evidence systems that track performance, antimicrobial reduction outcomes, animal welfare indicators, productivity metrics, and producer return on investment.

Research Methodology

This executive summary is developed using secondary research from recognized public sources, including global One Health guidance, veterinary antimicrobial stewardship frameworks, regulatory agency publications, peer-reviewed scientific literature, animal production databases, and animal health industry reports.

The methodology applies triangulation across regulatory evidence, scientific feasibility, production-system relevance, and commercial adoption indicators. Insights are validated by comparing policy direction, animal production trends, antimicrobial resistance priorities, technology readiness, and regional market conditions. Claims are limited to evidence-supported observations and do not rely on speculative market sizing, market share, or forecasting.

Conclusion and Strategic Outlook

Animal antibacterial peptides are positioned at the intersection of antimicrobial stewardship, precision animal health, and sustainable protein production. Their market relevance is rising as producers and veterinarians seek effective tools that can reduce dependence on conventional antibiotics without compromising animal welfare, productivity, or food safety.

The strongest opportunities will favor organizations that combine peptide science with validated delivery systems, regulatory discipline, AI-enabled discovery, scalable manufacturing, and practical farm-level economics. As resistance concerns and food safety expectations intensify, animal antibacterial peptides can become an important component of integrated disease prevention and responsible animal health management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Animal Antibacterial Peptide Market, by Product Type

  • 7.1. Naturally Derived Peptide
  • 7.2. Synthetic Peptide
    • 7.2.1. Long Chain
    • 7.2.2. Medium Chain
    • 7.2.3. Short Chain

8. Animal Antibacterial Peptide Market, by Animal Type

  • 8.1. Food-Producing Animals
    • 8.1.1. Cattle
    • 8.1.2. Poultry
    • 8.1.3. Swine
  • 8.2. Companion Animals
    • 8.2.1. Dogs
    • 8.2.2. Cats

9. Animal Antibacterial Peptide Market, by Mode of Delivery

  • 9.1. Oral
  • 9.2. Injectable
  • 9.3. Topical

10. Animal Antibacterial Peptide Market, by Application

  • 10.1. Growth Promotion
  • 10.2. Prophylactic
    • 10.2.1. Disease Prevention
    • 10.2.2. Vaccination Adjuvant
  • 10.3. Therapeutic
    • 10.3.1. Infection Treatment
    • 10.3.2. Skin Disease Treatment

11. Animal Antibacterial Peptide Market, by End User

  • 11.1. Aquaculture Farms
  • 11.2. Feed Manufacturers
    • 11.2.1. Aquafeed
    • 11.2.2. Livestock Feed
  • 11.3. Research Institutes
    • 11.3.1. Academic Institute
    • 11.3.2. Biotech Company
  • 11.4. Veterinary Clinics
    • 11.4.1. Large Animal Practice
    • 11.4.2. Small Animal Practice

12. Animal Antibacterial Peptide Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Animal Antibacterial Peptide Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Animal Antibacterial Peptide Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. AB Vista Limited
  • 16.2. AgroBioTek Laboratories LLC
  • 16.3. Anitox Corporation
  • 16.4. Biogenesis Bago S.A.
  • 16.5. Biosynth Ltd
  • 16.6. Boehringer Ingelheim International GmbH
  • 16.7. Cargill, Incorporated
  • 16.8. Dechra Pharmaceuticals PLC
  • 16.9. Eco Animal Health Ltd.
  • 16.10. Elanco Animal Health Incorporated
  • 16.11. Esco Aster Pte. Ltd.
  • 16.12. Genera Inc.
  • 16.13. Huvepharma S.A.
  • 16.14. ImmuCell Corporation
  • 16.15. Kemin Industries, Inc.
  • 16.16. Merck & Co., Inc.
  • 16.17. Neogen Corporation
  • 16.18. Novozymes A/S
  • 16.19. Phibro Animal Health Corporation
  • 16.20. Vetbiochem India Pvt Ltd.
  • 16.21. Vetoquinol S.A.
  • 16.22. Zoetis Inc.
  • 16.23. Zomedica Pharmaceuticals Corp.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NATURALLY DERIVED PEPTIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NATURALLY DERIVED PEPTIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NATURALLY DERIVED PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SYNTHETIC PEPTIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SYNTHETIC PEPTIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SYNTHETIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LONG CHAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LONG CHAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LONG CHAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDIUM CHAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDIUM CHAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDIUM CHAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SHORT CHAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SHORT CHAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SHORT CHAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GROWTH PROMOTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GROWTH PROMOTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GROWTH PROMOTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PROPHYLACTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PROPHYLACTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PROPHYLACTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DISEASE PREVENTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DISEASE PREVENTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DISEASE PREVENTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VACCINATION ADJUVANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VACCINATION ADJUVANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VACCINATION ADJUVANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INFECTION TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INFECTION TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INFECTION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SKIN DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SKIN DISEASE TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SKIN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FEED MANUFACTURERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FEED MANUFACTURERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FEED MANUFACTURERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AQUAFEED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AQUAFEED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AQUAFEED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LIVESTOCK FEED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL LIVESTOCK FEED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LIVESTOCK FEED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ACADEMIC INSTITUTE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACADEMIC INSTITUTE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ACADEMIC INSTITUTE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOTECH COMPANY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOTECH COMPANY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOTECH COMPANY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL LARGE ANIMAL PRACTICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL LARGE ANIMAL PRACTICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL LARGE ANIMAL PRACTICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SMALL ANIMAL PRACTICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SMALL ANIMAL PRACTICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SMALL ANIMAL PRACTICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 203. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 212. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 213. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 216. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 248. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 252. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 254. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 255. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 257. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 258. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 262. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 264. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 265. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 266. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 268. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 269. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 271. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 272. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 293. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 294. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 295. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 297. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 298. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 300. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 301. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 302. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 305. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 307. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 308. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 309. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 310. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 311. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 312. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 314. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 315. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 319. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 321. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 322. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 323. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
  • TABLE 325. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 326. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 328. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 329. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 338. UNI